Science & Technology

Inter-alpha Inhibitors in Hypoxic-Ischemic Brain Injury

Department of Health and Human Services — National Institutes of Health

Opportunity #: 2R44NS084575-04

Award Ceiling

$2.8M

Award Floor

$2.8M

Close Date

Aug 31, 2026

169 days left

Total Funding

$2.8M

Expected Awards

Posted Date

Sep 8, 2023

Cost Sharing Required

Grants.gov ID

sbir-2R44NS084575-04

Description

SBIR Phase Phase II award: "Inter-alpha Inhibitors in Hypoxic-Ischemic Brain Injury" awarded to PROTHERA BIOLOGICS, INC. in PROVIDENCE, Rhode Island. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $2,776,920. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.

Eligible Applicants

Small businesses

Apply on Grants.gov

Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.

View on Grants.gov

Disclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.